A comparative analysis of the expression levels of linc00907 in these models and normal mouse livers revealed a distinct upregulation of linc00907 in both NAFLD and NASH conditions, with the latter demonstrating a more pronounced expression (Figure 2B). This evidence concerns the gene LINC00907 and metabolic dysfunction-associated steatotic liver disease.